VA106483 Dose Response in Females
Completed · Phase 1 · Has a placebo group
Conditions studied: Nocturia
In brief
The purpose of this study is to describe the pharmacokinetics and pharmacodynamics of VA106483 in female subjects.
Key facts
- Study ID
- NCT01171391
- Run by
- Vantia Ltd
- People needed
- 21
- Starts
- 2010-07-01
- Expected to finish
- 2010-11-01
- Last updated by the study team
- 2010-12-01
Who can join
Age: 40 and older. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Female subjects 40 years and above
- BMI 18 to 32 kg/m2
- Using adequate contraception and providing negative pregnancy tests pre-dose
- In good health as determined by medical history and screening tests
- Subject is willing and able to abstain from alcohol and caffeine-containing food and beverages 72 hours prior to dosing and throughout the study
- Provide written, informed consent
You may not qualify if…
- Pregnancy or lactation
- Evidence of serious pathology or diseases including heart, hormone, liver and kidney, psychiatric and neurological problems, including syndrome of inappropriate antidiuretic hormone secretion, polydipsia or diabetes insipidus
- Likely to be hypersensitive to VA106483
- History of any relevant allergy
- Participation in a clinical study within 30 days
- Donation of blood (500 mL) within 60 days prior to dosing
- A history of alcohol abuse or drug addiction
- Positive results for HIV, HBV or HCV or drugs of abuse
- Currently taking any diuretics or clinically significant cytochrome 3A4 inhibitors or inducers
- Use of any non-prescription preparation within 72 hours prior to dosing, with the exception of ibuprofen, and acetaminophen used at recommended doses
- Treatment within the previous 3 months of drugs known to have a well defined potential for hepatoxicity
- Current smokers or recent ex-smokers
- Other protocol defined eligibility criteria may apply
Where it is running
- Quintiles Phase I Services — Overland Park, Kansas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.